{"signature": "0x648086ff0d6ed76b72ac3df3442035eb3ab095c46f241975b8c27dfa29fc51223aedbfe397cec8e4aaac31af59b43a27d0d92c3132005159bbf48e5ab06a2c2e1b", "application": {"round": "0xadef139d93bcdf9998e08b0d472b7a2681a1b80a", "answers": [], "project": {"id": "0x4707878e48e29afd854e5161627d56a169a3e9b2d572cb2cf39c230cbb523f89", "title": "inducible gene switching", "logoImg": "bafkreihmdbjuf6kpsrjwsbrwmy5oz357xwv3xiwwcq5svp53fr4py34rae", "metaPtr": {"pointer": "bafkreiab7ffvq3csninicttdfl3qoovh2fisekkcnj4wqyftzqgdzxzvl4", "protocol": "undefined"}, "website": "https://Sites.google.com/view/genswitch/home", "bannerImg": "bafkreiaiku3gzwabx44swu3eie6wxt7gz5ajqusaetvowbg5ziroykorba", "createdAt": 1724800991484, "credentials": {}, "description": "We will make safe,  inducible gene switches for gene therapies and CAR-T interventions. This will allow for the creation of completely reversible gene therapies, as well as CAR-T cells that function in a dose-dependent manner. This will dramatically improve the safety profiles of these therapies.", "lastUpdated": 0}, "recipient": "0xE69DE867223df144f5633A9527a4b18bF7125C62"}}